Since 2022, four GLP-1 drugs, including those indicated for weight loss, have been on FDA’s drug shortage list due to extraordinarily high patient demand. The shortage has, in turn, resulted in ...

Add Yahoo as a preferred source to see more of our stories on Google. Patients have been buying compounded weight loss drugs at lower prices than brand-name medications amid shortages of tirzepatide ...

Custom formulations of popular weight loss medications have surged in popularity due to the high costs of FDA-approved drugs. Here’s what to know about their benefits and risks.

The FDA’s ban on compounded diabetes and weight loss drugs took effect on May 22. Here’s what to know if you’d been taking one. The FDA has banned compounded versions of GLP-1 drugs like semaglutide ...

Agnes Juang, Ph.D., Makoto Tsunozaki Ph.D. In an attempt to prevent compounding of its drug products, Novo Nordisk has taken action against compounding pharmacies under federal trademark as well as ...

Strive Compounding Pharmacy sues Eli Lilly and Novo Nordisk over alleged GLP-1 weight loss drug competition limits. Read more here.

The roughly $1,000 monthly price tag of Eli Lilly's weight loss drug Zepbound put the blockbuster treatment out of reach for Willow Baillies, 29, whose insurance does not cover it. Baillies, a human ...

Drug shortages continue to impact anesthesiology and compounding pharmacies may be key for supply, according to MedPageToday. At the recent American Society of Anesthesiologists meeting, clinicians ...

The repeat problems at Houston-based Empower Pharmacy include inadequate quality testing and a failure to clean equipment.

Drugmakers Eli Lilly and Novo Nordisk have been sued in Texas by a compounding pharmacy that alleges they are illegally blocking access to customized versions of their blockbuster weight-loss ...